2022
DOI: 10.1016/j.compositesb.2022.110085
|View full text |Cite
|
Sign up to set email alerts
|

Construction of poly-(γ-benzyl‐l‐glutamate) composite microcarriers with osteogenic and angiogenic properties for the restoration of alveolar bone defects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 61 publications
0
2
0
Order By: Relevance
“…In comparison to the other groups, CuS@MSN-SCS exhibited a significantly higher level of CD31-positive angiogenesis (Figure C). This can be attributed to the presence of Cu 2+ ions and SCS derived from CuS@MSN-SCS. , These findings suggest that CuS@MSN-SCS possesses the capacity to alleviate inflammation and accelerate neovascularization for alveolar bone regeneration, thus exhibiting a noteworthy therapeutic effect on periodontitis in vivo .…”
Section: Resultsmentioning
confidence: 85%
“…In comparison to the other groups, CuS@MSN-SCS exhibited a significantly higher level of CD31-positive angiogenesis (Figure C). This can be attributed to the presence of Cu 2+ ions and SCS derived from CuS@MSN-SCS. , These findings suggest that CuS@MSN-SCS possesses the capacity to alleviate inflammation and accelerate neovascularization for alveolar bone regeneration, thus exhibiting a noteworthy therapeutic effect on periodontitis in vivo .…”
Section: Resultsmentioning
confidence: 85%
“…PLGA-CAS was prepared using the double emulsion method [31,32]. First, 100 mg of PLGA was dissolved in 3 mL of DCM as the oil phase (O).…”
Section: Preparation Of μHa/plga-cas and Nha/plga-casmentioning
confidence: 99%
“…Consequently, the last few decades have witnessed the introduction of myriad vascularization strategies within the realms of tissue engineering and regenerative medicine [ 2 , 3 ]. While prior investigations predominantly focused on approaches such as the addition of growth factors, prefabricated vascular networks, and vascular transplantation, these methodologies have grappled with issues of low efficiency and security during practical implementation [ 4 ]. Addressing these challenges necessitates an exploration of the autologous tissue vascularization strategy, which mitigates the risk of disease transmission and obviates the need for post-implantation immunosuppression.…”
Section: Introductionmentioning
confidence: 99%